Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $74.49 is 218.20% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 74.50||$ 85|
|Low:||$ 74.1405||$ 23.41|
ETFs with TSRO as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.15%||SPDR Series Trust SPDR S&P Biotech ETF (XBI)||-20.05 (-20.02%)|
|2.76%||iShares U.S. Pharmaceutical ETF (IHE)||-3.19 (-2.02%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
We are a commercial-stage biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. Our primary focus is to develop treatments for solid tumors using various approaches, including small molecules and immuno-oncology antibodies, as monotherapies or in combinations. We have in-licensed and are developing several oncology-related product candidates, and we have entered into several research collaborations with third parties for the discovery of new candidates. We have also entered into arrangements with other companies for the development and commercialization of certain of our product candidates in specific indications and/or geographies. To date, we have received regulatory approvals for the following products, which are currently marketed and sold in the U.S. and in certain countries in Europe: · The U.S. ... More ...
Nasdaq Official Price
Dec. 13, 2018
Dec. 13, 2018